Leyton is proud to support the biotechnology sector through its new partner One Nucleus
Leyton, the R&D Tax Credit advisory firm is pleased to announce a partnership with Cambridge and London based life science organisation One Nucleus for the provision of discounted advisory services on R&D Tax Credit claim handling and HMRC audits.
Benefiting from the highly experienced in-house technical consultant team at Leyton who will undertake the services, One Nucleus members large and small will benefit from a reduced fee rate which could translate into significant savings to the claimant company. One Nucleus members will receive a free initial consultation, providing them with the confidence that there is a value and benefit to proceeding with the R&D and a capital allowance claim process. Based on their success-fee offering, the Leyton offering also includes a free defence service in the event of an audit by HMRC, confirming their confidence in standing by their work and advice.
William Garvey, Managing Director at Leyton said, “We see working with One Nucleus members as a long term commitment to engage with and support the high growth life science companies undertaking research and development in the UK. Assisting the companies in establishing best practice recording and monitoring of their R&D spend will enable their senior management to quickly assess the potential benefits of making a claim”.
Harriet Fear, CEO of One Nucleus commented, “Capital efficiency has become a hallmark of UK-grown research companies and this has never been more important given the current economic environment. We are delighted to be working with Leyton to reduce the cost to our members of securing expert advice in optimising the return on their capital by taking maximum benefit of HMRC incentives.”